Your request to link to rcsb for CAM-BPTI

  • 1CBW: bovine chymotrypsin complexed to bpti
  • 1CO7: r117h mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti)
  • 1D0D: crystal structure of tick anticoagulant protein complexed with bovine pancreatic trypsin inhibitor
  • 1EAW: crystal structure of the mtsp1 (matriptase)-bpti (aprotinin) complex (10.1074/JBC.M109830200 )
  • 1EJM: crystal structure of the bpti ala16leu mutant in complex with bovine trypsin (10.1006/JMBI.2000.3935 )
  • 1F5R: rat trypsinogen mutant complexed with bovine pancreatic trypsin inhibitor (10.1110/PS.44101 )
  • 1F7Z: rat trypsinogen k15a complexed with bovine pancreatic trypsin inhibitor (10.1110/PS.44101 )
  • 1FAK: human tissue factor complexed with coagulation factor viia inhibited with a bpti-mutant (10.1006/JMBI.1998.2452 )
  • 1FAN: crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of f22a, y23a, n43g, and f45a
  • 1FY8: crystal structure of the deltaile16val17 rat anionic trypsinogen-bpti complex (10.1110/PS.44101 )
  • 1G6X: ultra high resolution structure of bovine pancreatic trypsin inhibitor (bpti) mutant with altered binding loop sequence (10.1107/S0907444901003468 )
  • 1JV8: nmr structure of bpti mutant g37a (10.1021/BI011693E )
  • 1JV9: nmr structure of bpti mutant g37a (10.1021/BI011693E )
  • 1K6U: crystal structure of cyclic bovine pancreatic trypsin inhibitor (10.1016/S0014-5793(01)03113-1 )
  • 1LD5: structure of bpti mutant a16v (10.1016/S0022-2836(02)00620-4 )
  • 1MTN: bovine alpha-chymotrypsin:bpti crystallization
  • 1NAG: crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of f22a, y23a, n43g, and f45a
  • 1OA5: the solution structure of bovine pancreatic trypsin inhibitor at high pressure (10.1110/PS.0242103 )
  • 1OA6: the solution structure of bovine pancreatic trypsin inhibitor at high pressure (10.1110/PS.0242103 )
  • 1P2I: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2J: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2K: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2M: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2N: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2O: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1P2Q: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
  • 1PIT: determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures (10.1016/0022-2836(92)90222-6 )
  • 1QLQ: bovine pancreatic trypsin inhibitor (bpti) mutant with altered binding loop sequence 06-jun-18 1qlq 1 title (10.1006/JMBI.1999.3445 )
  • 1T7C: crystal structure of the p1 glu bpti mutant- bovine chymotrypsin complex (10.1016/J.JMB.2004.09.088 )
  • 1T8L: crystal structure of the p1 met bpti mutant- bovine chymotrypsin complex (10.1016/J.JMB.2004.09.088 )
  • 1T8M: crystal structure of the p1 his bpti mutant- bovine chymotrypsin complex (10.1016/J.JMB.2004.09.088 )
  • 1T8N: crystal structure of the p1 thr bpti mutant- bovine chymotrypsin complex (10.1016/J.JMB.2004.09.088 )
  • 1T8O: crystal structure of the p1 trp bpti mutant- bovine chymotrypsin complex (10.1016/J.JMB.2004.09.088 )
  • 1TPA: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
  • 1UUA: solution structure of a truncated bovine pancreatic trypsin inhibitor, 3-58 bpti. 17-jan-18 1uua 1 title
  • 1UUB: solution structure of a truncated bovine pancreatic trypsin inhibitor mutant, 3-58 bpti (k15r, r17a, r42s)
  • 1YKT: trypsin/bpti complex mutant (10.1016/J.JMB.2007.10.084 )
  • 1YLC: trypsin/bpti complex mutant (10.1016/J.JMB.2007.10.084 )
  • 1YLD: trypsin/bpti complex mutant (10.1016/J.JMB.2007.10.084 )
  • 2FI3: crystal structure of a bpti variant (cys14->ser, cys38->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
  • 2FI4: crystal structure of a bpti variant (cys14->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
  • 2FI5: crystal structure of a bpti variant (cys38->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
  • 2FTL: crystal structure of trypsin complexed with bpti at 100k (10.1016/J.JMB.2006.11.003 )
  • 2FTM: crystal structure of trypsin complexed with the bpti variant (tyr35- >gly) (10.1016/J.JMB.2006.11.003 )
  • 2HEX: decamers observed in the crystals of bovine pancreatic trypsin inhibitor (10.1107/S0907444998011068 )
  • 2IJO: crystal structure of the west nile virus ns2b-ns3 protease complexed with bovine pancreatic trypsin inhibitor (10.1110/PS.072753207 )
  • 2KAI: refined 2.5 angstroms x-ray crystal structure of the complex formed by porcine kallikrein a and the bovine pancreatic trypsin inhibitor. crystallization, patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin- pancreatic trypsin inhibitor complex (10.1016/0022-2836(83)90078-5 )
  • 2PTC: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
  • 2R9P: human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(bpti) (10.1074/JBC.M708268200 )
  • 2RA3: human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti) (10.1074/JBC.M708268200 )
  • 2TGP: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
  • 2TPI: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
  • 2ZJX: bovine pancreatic trypsin inhibitor (bpti) containing only the [5,55] disulfide bond (10.1073/PNAS.0802699105 )
  • 2ZVX: structure of a bpti-[5,55] variant containing gly/val at the 14/38th positions (10.1002/PROT.22522 )
  • 3BTD: the crystal structures of the complexes between the bovine beta- trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
  • 3BTE: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
  • 3BTF: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
  • 3BTG: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTH: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTK: the crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTM: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTQ: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTT: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3BTW: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
  • 3FP6: anionic trypsin in complex with bovine pancreatic trypsin inhibitor (bpti) determined to the 1.49 a resolution limit (10.1073/PNAS.0902463106 )
  • 3FP7: anionic trypsin variant s195a in complex with bovine pancreatic trypsin inhibitor (bpti) cleaved at the scissile bond (lys15-ala16) determined to the 1.46 a resolution limit (10.1073/PNAS.0902463106 )
  • 3FP8: anionic trypsin variant s195a in complex with bovine pancreatic trypsin inhibitor (bpti) determined to the 1.46 a resolution limit (10.1073/PNAS.0902463106 )
  • 3GYM: structure of prostasin in complex with aprotinin (10.1002/PRO.118 )
  • 3LDI: crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implication for heparin binding (10.1016/J.BBRC.2010.05.113 )
  • 3LDJ: crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implication for heparin binding (10.1016/J.BBRC.2010.05.113 )
  • 3LDM: crystal structure of aprotinin in complex with sucrose octasulfate: unusual interactions and implication for heparin binding (10.1016/J.BBRC.2010.05.113 )
  • 3OTJ: a crystal structure of trypsin complexed with bpti (bovine pancreatic trypsin inhibitor) by x-ray/neutron joint refinement (10.1107/S0907444910053382 )
  • 3P92: human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (bpti-k15r/r17g) (10.1042/BJ20110788 )
  • 3P95: human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (bpti-k15r/r17d) (10.1042/BJ20110788 )
  • 3TGI: wild-type rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (bpti)
  • 3TGJ: s195a trypsinogen complexed with bovine pancreatic trypsin inhibitor (bpti)
  • 3TGK: trypsinogen mutant d194n and deletion of ile 16-val 17 complexed with bovine pancreatic trypsin inhibitor (bpti) (10.1110/PS.44101 )
  • 3TPI: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
  • 3U1J: aprotinin bound to dengue virus protease (10.1128/JVI.06225-11 )
  • 4BNR: extremely stable complex of crayfish trypsin with bovine trypsin inhibitor (10.1111/FEBS.12491 )
  • 4DG4: human mesotrypsin-s39y complexed with bovine pancreatic trypsin inhibitor (bpti) (10.1002/PRO.2097 )
  • 4PTI: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
  • 4TPI: the refined 2.2-angstroms (0.22-nm) x-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the arg15 analogue of bovine pancreatic trypsin inhibitor (10.1111/J.1432-1033.1984.TB08447.X )
  • 4WWY: human cationic trypsin g193r mutant in complex with bovine pancreatic trypsin inhibitor (10.1074/JBC.M115.662429 )
  • 4WXV: human cationic trypsin k97d mutant in complex with bovine pancreatic trypsin inhibitor (bpti) (10.1074/JBC.M115.662429 )
  • 4Y0Y: trypsin in complex with with bpti (10.1039/C4SC03227F )
  • 4Y0Z: trypsin in complex with with bpti mutant aminobutyric acid (10.1039/C4SC03227F )
  • 4Y10: trypsin in complex with with bpti mutant (2s)-2-amino-4,4- difluorobutanoic acid (10.1039/C4SC03227F )
  • 4Y11: trypsin in complex with with bpti mutant (2s)-2-amino-4,4,4- trifluorobutanoic acid (10.1039/C4SC03227F )
  • 5PTI: structure of bovine pancreatic trypsin inhibitor. results of joint neutron and x-ray refinement of crystal form ii (10.1016/S0022-2836(84)80006-6 )
  • 5XX2: a bpti-[5,55] variant with c14ga38l mutations (10.1111/FEBS.14941 )
  • 5XX3: a bpti-[5,55] variant with c14ga38g mutations (10.1111/FEBS.14941 )
  • 5XX4: a bpti-[5,55] variant with c14ga38k mutations (10.1111/FEBS.14941 )
  • 5XX5: a bpti-[5,55] variant with c14ga38i mutations (10.1111/FEBS.14941 )
  • 5XX6: hetero-micro-seeding: crystal structure of bpti-[5,55]c14ga38i variant using micro-seeds from -c14ga38g variant (10.1016/J.BBRC.2017.08.161 )
  • 5XX7: hetero-micro-seeding: crystal structure of bpti-[5,55]c14ga38i variant using micro-seeds from -c14ga38i variant (10.1016/J.BBRC.2017.08.161 )
  • 5XX8: hetero-micro-seeding: crystal structure of bpti-[555]c14ga38i variant using micro-seeds from -c14ga38l variant (10.1016/J.BBRC.2017.08.161 )
  • 5YVU: crystal structures of unlinked full length ns3 from dengue virus provide insights into dynamics of protease domain
  • 5YW1: crystal structure of full length ns3 protein (ed4ns2bns3) in complex with bovine pancreatic trypsin inhibitor
  • 6F1F: the methylene thioacetal bpti (bovine pancreatic trypsin inhibitor) mutant structure (10.1039/C8SC01110A )
  • 6PTI: structure of form iii crystals of bovine pancreatic trypsin inhibitor (10.1016/0022-2836(87)90294-4 )
  • 7PH1: trypsin in complex with bpti mutant (2s)-2-amino-4-monofluorobutanoic acid
  • 7PTI: structural effects induced by removal of a disulfide bridge. the x-ray structure of the c30a(slash)c51a mutant of basic pancreatic trypsin inhibitor at 1.6 angstroms (10.1093/PROTEIN/3.7.591 )
  • 7QIQ: crystal structure of the p1 aminobutanoic acid (abu) bpti mutant- bovine chymotrypsin complex
  • 7QIR: crystal structure of the p1 monofluorethylglycine(mfegly) bpti mutant- bovine chymotrypsin complex
  • 7QIS: crystal structure of the p1 difluoroethylglycine (dfegly) bpti mutant- bovine chymotrypsin complex
  • 7QIT: crystal structure of the p1 trifluoroethylglycine (tfegly) bpti mutant- bovine chymotrypsin complex
  • 8PTI: crystal structure of a y35g mutant of bovine pancreatic trypsin inhibitor (10.1016/0022-2836(91)90115-M )
  • 9PTI: basic pancreatic trypsin inhibitor (met 52 oxidized)